BRIEF—Daiichi Sankyo sells Takatsuki-based facility

Japan’s Daiichi Sankyo has agreed terms with Taiyo Holdings to sell its Takatsuki-based plant, which is responsible for manufacturing pharmaceuticals.

Daiichi says it will “continue to utilize its advanced technological capabilities and production capacity,” and that the sale is aimed at establishing “a high-quality, more efficient production system.”

The consideration for the transfer of shares is expected to be 37.6 billion yen ($345 million).